Mersana Therapeutics
Utility Patent Applications

Last updated:

List of all Mersana Therapeutics patents 8 in total

Status Patent
Application
Utility: B7H4-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: STING AGONIST COMPOUNDS AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: SITE SPECIFIC ANTIBODY-DRUG CONJUGATES WITH PEPTIDE-CONTAINING LINKERS External link
Filling date: 6 Sep 2025 Issue date: 22 Jul 2021
Application
Utility: PROTEIN-POLYMER-DRUG CONJUGATES External link
Filling date: 6 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: STING AGONIST COMPOUNDS AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 30 Jan 2020

Showing 1 to 8 of 8 patents.